The method generally used for detecting immune complexes is examination of a tissue obtained by biopsy (removal and examination of tissue sample) and the subsequent use of different staining techniques with specific antibodies.
The purpose of the immune complex test is to demonstrate circulating immune complexes in the blood, to estimate the severity of immune complex disease, and to monitor response to therapy.
Normally, immune complexes are not detected in the blood.
This test requires a blood sample. It is not necessary for the patient to be in a fasting (nothing to eat or drink) state before the test.
The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations.
Because this test is requested when the physician suspects that a patient's immune system is not functioning properly, special care should be taken during and after blood is drawn. For example, the venipuncture site should be kept clean.
The presence of detectable immune complexes in the blood is important in the diagnosis of autoimmune diseases, such as SLE and rheumatoid arthritis. However, for definitive diagnosis, the results of other studies must be considered.
Risks for this test are minimal, but may include slight bleeding from the blood-drawing site, fainting or feeling lightheaded after venipuncture, or hematoma (blood accumulating under the puncture site).
Exposure to asbestos will likely compromise the immune system because of the long-term stress to the body. The test for asbestos exposure does not affect the immune system.
Rocket Propulsion Test Complex was created in 1965.
by producing an immune response
The immune system and transplant medicine.
Immune System